These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9029083)

  • 1. Cutting edge: CD4+ T cells kill CD8+ T cells via Fas/Fas ligand-mediated apoptosis.
    Piazza C; Gilardini Montani MS; Moretti S; Cundari E; Piccolella E
    J Immunol; 1997 Feb; 158(4):1503-6. PubMed ID: 9029083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of immune responses by CD8 cells. I. Superantigen-activated CD8 cells induce unidirectional Fas-mediated apoptosis of antigen-activated CD4 cells.
    Noble A; Pestano GA; Cantor H
    J Immunol; 1998 Jan; 160(2):559-65. PubMed ID: 9551888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones.
    Esser MT; Dinglasan RD; Krishnamurthy B; Gullo CA; Graham MB; Braciale VL
    J Immunol; 1997 Jun; 158(12):5612-8. PubMed ID: 9190908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas/Fas ligand interaction regulates cytotoxicity of CD4+ T cells against staphylococcal enterotoxin B-pulsed endothelial cells.
    Urayama S; Kawakami A; Matsuoka N; Tsuboi M; Nakashima T; Kawabe Y; Koji T; Eguchi K
    Biochem Biophys Res Commun; 1997 Oct; 239(3):782-8. PubMed ID: 9367846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
    Rivoltini L; Radrizzani M; Accornero P; Squarcina P; Chiodoni C; Mazzocchi A; Castelli C; Tarsini P; Viggiano V; Belli F; Colombo MP; Parmiani G
    J Immunol; 1998 Aug; 161(3):1220-30. PubMed ID: 9686582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of human B cell responsiveness by CD4+ T cells does not involve CD95-CD95 ligand interactions.
    Hirohata S
    Cell Immunol; 1997 Nov; 181(2):182-91. PubMed ID: 9398405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in sensitivity of peripheral lymphocytes of autoimmune gld mice to FasL-mediated apoptosis reveal a mechanism for the preferential deletion of CD4-CD8-B220+ T cells.
    Xiao S; Zhang X; Mann KK; Jodo S; Li L; Jarjour WN; Marshak-Rothstein A; Sherr DH; Ju ST
    Int Immunol; 2004 May; 16(5):759-66. PubMed ID: 15096479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas-FasL-mediated CD4+ T-cell apoptosis following stem cell transplantation.
    Singh RK; Varney ML; Buyukberber S; Ino K; Ageitos AG; Reed E; Tarantolo S; Talmadge JE
    Cancer Res; 1999 Jul; 59(13):3107-11. PubMed ID: 10397252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased lymphocyte apoptosis in Fas ligand transgenic mice.
    Cheng J; Liu C; Yang P; Zhou T; Mountz JD
    J Immunol; 1997 Jul; 159(2):674-84. PubMed ID: 9218582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocytes express Fas ligand upon CD4 cross-linking and induce CD4+ T cells apoptosis: a possible mechanism of bystander cell death in HIV infection.
    Oyaizu N; Adachi Y; Hashimoto F; McCloskey TW; Hosaka N; Kayagaki N; Yagita H; Pahwa S
    J Immunol; 1997 Mar; 158(5):2456-63. PubMed ID: 9036997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perforin-dependent cytotoxic activity and lymphokine secretion by CD4+ T cells are regulated by CD8+ T cells.
    Williams NS; Engelhard VH
    J Immunol; 1997 Sep; 159(5):2091-9. PubMed ID: 9278294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
    Elsässer-Beile U; Gierschner D; Welchner T; Wetterauer U
    Anticancer Res; 2003; 23(1A):433-7. PubMed ID: 12680244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ T cells reactivated with superantigen are both more sensitive to FasL-mediated killing and express a higher level of FasL.
    Wang JK; Zhu B; Ju ST; Tschopp J; Marshak-Rothstein A
    Cell Immunol; 1997 Aug; 179(2):153-64. PubMed ID: 9268499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms.
    Lewinsohn DM; Bement TT; Xu J; Lynch DH; Grabstein KH; Reed SG; Alderson MR
    J Immunol; 1998 Mar; 160(5):2374-9. PubMed ID: 9498779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells.
    Gehri R; Hahn S; Rothen M; Steuerwald M; Nuesch R; Erb P
    AIDS; 1996 Jan; 10(1):9-16. PubMed ID: 8924258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of activated but not resting primary human CD4+ and CD8+ T cells by Fas ligand (FasL/CD95L)-expressing Killer-dendritic cells.
    Hoves S; Krause SW; Herfarth H; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
    Immunobiology; 2004; 208(5):463-75. PubMed ID: 15124861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Fas death pathway controls coordinated expansions of type 1 CD8 and type 2 CD4 T cells in Trypanosoma cruzi infection.
    Guillermo LV; Silva EM; Ribeiro-Gomes FL; De Meis J; Pereira WF; Yagita H; DosReis GA; Lopes MF
    J Leukoc Biol; 2007 Apr; 81(4):942-51. PubMed ID: 17261545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD95 (Fas)-based, superantigen-dependent, CD4+ T cell-mediated down-regulation of human in vitro immunoglobulin responses.
    Stohl W; Elliott JE; Lynch DH; Kiener PA
    J Immunol; 1998 Jun; 160(11):5231-8. PubMed ID: 9605118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway.
    Porakishvili N; Kardava L; Jewell AP; Yong K; Glennie MJ; Akbar A; Lydyard PM
    Haematologica; 2004 Apr; 89(4):435-43. PubMed ID: 15075077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.